RxDoctor Payments Data

Adebayo Akinsola

Pediatrics · Chamblee, GANPI 1407086879

Payments from drug & device makers

What this record shows

Modernatx, Inc. accounts for 88.9% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $2,631 and has fallen 94.6% since, to $141 in 2025. Among pediatrics clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,959in general payments, 2019–2025

Across 26 payments — averaging $113.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$3K
  • Sanofi Pasteur Inc.$119
  • Merck$89
  • GSK$52
  • Cranial Technologies, Inc$45
  • Pfizer$22
$6,392,324in research payments, 2019–2025

Across 2,239 payments — averaging $2854.99 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Modernatx, Inc.$4.3M
  • Pfizer$588K
  • Bavarian Nordic A/s$505K
  • Sanofi Pasteur Inc.$315K
  • GSK$309K
  • Novavax Inc$145K
  • plus $209K from 4 others

What the payments were for

  • Travel & lodging$1,74559%
  • Food & beverage$1,21441%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,959 in reported general payments places this provider in the 95th percentile of 2,111 pediatrics providers in Georgia.

See all pediatrics providers in Georgia →

Other pediatrics in Chamblee

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →